Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

314 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Recruiting

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

NCT05765500

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute at Foxborough Foxborough, Massachusetts, United States
View Trial Details
Recruiting

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT07719361

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +15 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
View Trial Details
Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

NCT06136650

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • The University of Arizona Cancer Center - North Campus ( Site 0073) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0044) Los Angeles, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040) Orange, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center (0120) Orange, California, United States
View all 329 locations
View Trial Details
Recruiting

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

NCT06925737

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Mayo Clinic in Arizona - Phoenix ( Site 0044) Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center ( Site 0049) Duarte, California, United States
  • City of Hope Lennar Foundation Cancer Center ( Site 0059) Irvine, California, United States
  • Moores Cancer Center ( Site 0010) La Jolla, California, United States
View all 290 locations
View Trial Details
Recruiting

Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

NCT05918263

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions